SE435509B - Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt - Google Patents

Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt

Info

Publication number
SE435509B
SE435509B SE7711848A SE7711848A SE435509B SE 435509 B SE435509 B SE 435509B SE 7711848 A SE7711848 A SE 7711848A SE 7711848 A SE7711848 A SE 7711848A SE 435509 B SE435509 B SE 435509B
Authority
SE
Sweden
Prior art keywords
hydroxy
prepare
methyl
anabolic effect
isoflavon
Prior art date
Application number
SE7711848A
Other languages
English (en)
Swedish (sv)
Other versions
SE7711848L (sv
Inventor
L Feuer
L Farkas
M Nogradi
B Vermes
A Gottsegen
A Wolfner
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7711848L publication Critical patent/SE7711848L/xx
Publication of SE435509B publication Critical patent/SE435509B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
SE7711848A 1973-07-09 1977-10-20 Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt SE435509B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU37I1396A HU166380B (xx) 1973-07-09 1973-07-09

Publications (2)

Publication Number Publication Date
SE7711848L SE7711848L (sv) 1977-10-20
SE435509B true SE435509B (sv) 1984-10-01

Family

ID=10994486

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7408607A SE410264B (sv) 1973-07-09 1974-06-28 Foder med viktstegrande tillsats i form av isoflavonderivat
SE7711848A SE435509B (sv) 1973-07-09 1977-10-20 Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7408607A SE410264B (sv) 1973-07-09 1974-06-28 Foder med viktstegrande tillsats i form av isoflavonderivat

Country Status (23)

Country Link
US (1) US4163746A (xx)
JP (1) JPS6028836B2 (xx)
AR (1) AR204996A1 (xx)
AT (1) AT340231B (xx)
BG (1) BG21859A3 (xx)
CA (1) CA1033750A (xx)
CH (1) CH614950A5 (xx)
CS (1) CS181861B1 (xx)
DD (2) DD122090A1 (xx)
DE (1) DE2432799C2 (xx)
DK (1) DK365374A (xx)
ES (1) ES427963A1 (xx)
FR (1) FR2236493B1 (xx)
GB (1) GB1434451A (xx)
HU (1) HU166380B (xx)
IL (1) IL45123A (xx)
NL (1) NL178875C (xx)
NO (1) NO138713C (xx)
PL (1) PL90015B1 (xx)
RO (1) RO70162A (xx)
SE (2) SE410264B (xx)
SU (1) SU682099A3 (xx)
YU (1) YU182474A (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
JPS6048924A (ja) * 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
US4644012A (en) * 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
CH679584A5 (xx) * 1989-11-10 1992-03-13 Nestle Sa
US5278174A (en) * 1990-06-04 1994-01-11 Scios Nova, Inc. Sigma binding site agents
HUT68396A (en) * 1993-07-20 1995-04-25 Chinoin Gyogyszer Es Vegyeszet Method for preparing pharmaceutical preparation containing isoflavone derivative or salt of it
US5320949A (en) * 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
US6140469A (en) * 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5827682A (en) * 1995-06-07 1998-10-27 Protein Technologies International, Inc. Two-step conversion of vegetable protein isoflavone conjugates to aglucones
US5851792A (en) * 1996-04-03 1998-12-22 Shen; Jerome Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey
US6015785A (en) * 1996-04-12 2000-01-18 Protein Technologies International, Inc. Aglucone isofavone enriched vegetable protein extract and isolate and process for producing
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
RU2267279C2 (ru) * 1999-02-24 2006-01-10 Геза БРУКНЕР Диетическая композиция для уменьшения набора веса и способ уменьшения набора веса
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
DE60318059T2 (de) * 2002-07-23 2008-11-27 Dsm Ip Assets B.V. Herstellung von isoflavonen
CN103030619B (zh) * 2008-05-28 2015-04-22 中国医学科学院药物研究所 5-甲基-7-甲氧异黄酮的晶c型、其制法和其药物组合物与用途
CN101591324B (zh) * 2008-05-28 2013-07-10 中国医学科学院药物研究所 5-甲基-7-甲氧异黄酮的三种晶型、其制法和其药物组合物与用途
MX2012004118A (es) * 2009-10-09 2012-05-08 Nestec Sa Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales.
WO2023147289A1 (en) * 2022-01-25 2023-08-03 The Regents Of The University Of Colorado, A Body Corporate Treatment of genitourinary syndrome of menopause

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE586723A (fr) * 1960-01-19 1960-07-19 Sarec S A Nouveaux composes chimiques et thérapeutiques dérives des isoflavones, et leurs procédés de préparation.
HU162377B (xx) * 1970-05-27 1973-02-28

Also Published As

Publication number Publication date
GB1434451A (en) 1976-05-05
PL90015B1 (xx) 1976-12-31
NO138713C (no) 1978-11-01
NL178875C (nl) 1986-06-02
DD122090A1 (xx) 1976-09-12
NO138713B (no) 1978-07-24
SE410264B (sv) 1979-10-08
FR2236493A1 (xx) 1975-02-07
JPS6028836B2 (ja) 1985-07-06
DE2432799C2 (de) 1986-01-02
ES427963A1 (es) 1977-05-16
AR204996A1 (es) 1976-03-31
NO742470L (xx) 1975-02-03
SE7711848L (sv) 1977-10-20
SE7408607L (xx) 1975-01-10
CH614950A5 (en) 1979-12-28
US4163746A (en) 1979-08-07
IL45123A (en) 1977-12-30
NL178875B (nl) 1986-01-02
BG21859A3 (bg) 1976-09-20
FR2236493B1 (xx) 1977-07-08
JPS5037781A (xx) 1975-04-08
HU166380B (xx) 1975-03-28
RO70162A (ro) 1982-07-06
CS181861B1 (en) 1978-03-31
SU682099A3 (ru) 1979-08-25
DE2432799A1 (de) 1975-01-30
DK365374A (xx) 1975-03-03
IL45123A0 (en) 1974-09-10
NL7408995A (nl) 1975-01-13
ATA523774A (de) 1977-03-15
CA1033750A (en) 1978-06-27
DD115316A1 (xx) 1975-09-20
YU182474A (en) 1983-01-21
AT340231B (de) 1977-12-12

Similar Documents

Publication Publication Date Title
SE420717B (sv) Sett att framstella nya nonapeptidamidderivat med ovulationsinducerande aktivitet
SE435509B (sv) Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt
SE420718B (sv) Sett att framstella nya dekapeptidamidderivat med ovalationsinducerande aktivitet
SE401822B (sv) Sett att framstella nya nonapeptidamidderivat med ovulationsinducerande aktivitet
SE408426B (sv) Sett att framstella d-homo-20-ketopregnaner
SE417115C (sv) Sett att framstellning limmat papper med hartslim
SE412586B (sv) Sett att framstella isoflavonderivat
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE382215B (sv) Sett att framstella kromanderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
NO142477C (no) Triazolo-isoindol-derivater med befruktningshindrende virkning
SE399270B (sv) Sett att framstella spirolaktonsteroider
NO142079C (no) Triazolo-isokinolin-derivater med befruktningshindrende virkning
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE434050B (sv) Dihydrokinolinderivat med antioxiderande verkan jemte sett for deras framstellning
SE401184B (sv) Sett att framstella morfolinderivat
SE428471B (sv) Sett att framstella imidazolderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat